4th Circuit Reverses $1.25M Pradaxa Verdict: No New Evidence To Escape Preemption
RICHMOND, Va. — The Fourth Circuit U.S. Court of Appeals on Jan. 6 vacated a $1.25 million Pradaxa fraud verdict after finding there was no newly discovered information about risks from...To view the full article, register now.
Already a subscriber? Click here to view full article